C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebrospinal fluid. 1993

T Kaneko, and G Shirakami, and K Nakao, and I Nagata, and O Nakagawa, and N Hama, and S Suga, and S Miyamoto, and H Kubo, and O Hirai
Department of Neurosurgery, Kokura Memorial Hospital, Kitakyushu, Japan.

In order to investigate whether C-type natriuretic peptide (CNP) is present in human cerebrospinal fluid (CSF), we measured CNP-like immunoreactivity (-LI) in human CSF by specific radioimmunoassay (RIA) for CNP. We also measured atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) concentrations in human CSF. ANP-LI, BNP-LI, and CNP-LI concentrations of CSF collected from fifteen patients without neurological disorders were 0.20 +/- 0.13, 0.27 +/- 0.10, and 2.13 +/- 0.27 fmol/ml (mean +/- S.D.), respectively. In fifteen patients with neurological disorders, ANP-LI, BNP-LI, and CNP-LI concentrations in CSF were 0.21 +/- 0.18, 0.33 +/- 0.19, and 2.09 +/- 0.82 fmol/ml, respectively. Although ANP-LI and BNP-LI concentrations in plasma were much higher than those in CSF, CNP-LI was undetectable in plasma (less than 0.2 fmol/ml). These results demonstrate that three natriuretic peptides are present in CSF and that CNP is the major natriuretic peptide in human CSF. These results suggest that CNP in CSF is originated from and play important roles in the central nervous system.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Kaneko, and G Shirakami, and K Nakao, and I Nagata, and O Nakagawa, and N Hama, and S Suga, and S Miyamoto, and H Kubo, and O Hirai
December 1994, Endocrinology,
T Kaneko, and G Shirakami, and K Nakao, and I Nagata, and O Nakagawa, and N Hama, and S Suga, and S Miyamoto, and H Kubo, and O Hirai
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
T Kaneko, and G Shirakami, and K Nakao, and I Nagata, and O Nakagawa, and N Hama, and S Suga, and S Miyamoto, and H Kubo, and O Hirai
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
T Kaneko, and G Shirakami, and K Nakao, and I Nagata, and O Nakagawa, and N Hama, and S Suga, and S Miyamoto, and H Kubo, and O Hirai
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
T Kaneko, and G Shirakami, and K Nakao, and I Nagata, and O Nakagawa, and N Hama, and S Suga, and S Miyamoto, and H Kubo, and O Hirai
July 2014, Biochemical and biophysical research communications,
T Kaneko, and G Shirakami, and K Nakao, and I Nagata, and O Nakagawa, and N Hama, and S Suga, and S Miyamoto, and H Kubo, and O Hirai
August 1991, Endocrinology,
T Kaneko, and G Shirakami, and K Nakao, and I Nagata, and O Nakagawa, and N Hama, and S Suga, and S Miyamoto, and H Kubo, and O Hirai
April 2011, Peptides,
T Kaneko, and G Shirakami, and K Nakao, and I Nagata, and O Nakagawa, and N Hama, and S Suga, and S Miyamoto, and H Kubo, and O Hirai
April 1991, Science (New York, N.Y.),
T Kaneko, and G Shirakami, and K Nakao, and I Nagata, and O Nakagawa, and N Hama, and S Suga, and S Miyamoto, and H Kubo, and O Hirai
September 2009, Proceedings of the National Academy of Sciences of the United States of America,
T Kaneko, and G Shirakami, and K Nakao, and I Nagata, and O Nakagawa, and N Hama, and S Suga, and S Miyamoto, and H Kubo, and O Hirai
December 2003, Clinical calcium,
Copied contents to your clipboard!